Tag: healthcare
-
J&J filed for approval of Teclistamab for patients with refractory multiple myeloma
Johnson & Johnson (JNJ) has a current dividend yield of 2.47% and is rated as “Very Safe” by SimplySafeDividends. I hold JNJ in both my Low and Medium Yield Portfolios. In total JNJ is 1.4% of my portfolio. Johnson & Johnson’s Janssen Pharmaceutical Cos. unit on Wednesday said it filed for U.S. Food and Drug…
-
Coal in our stockings?
Market opens down over 1.5%, Senator Manchin tears down BBB, inflation in Reading PA., world on the verge of a Nutella shortage, and much much more!
-
CDC advisers recommend Pfizer or Moderna’s shots over Johnson & Johnson’s
The Advisory Committee on Immunization Practices voted 15 to 0 to make the recommendation Thursday after hearing updates from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with low blood-platelet levels. The updated position is likely to deal another blow to the use of the J&J…
-
Advisory committee to the CDC expected to update recommendation on Johnson & Johnson COVID vaccine
The Advisory Committee on Immunization Practices is hearing updates from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with low blood-platelet levels. The committee is expected to vote Thursday afternoon on whether to update its recommendation on use of the J&J vaccine, according to an agenda…
-
J splits with J
J&J will split in two, Shell will consolidate into one, gold hits new highs and much more!
-
Johnson & Johnson to split into two companies
No word yet on how this will affect stockholders and the dividend. Johnson & Johnson JNJ 1.19% plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry. The world’s largest health-products company by sales will…